Please enable JavaScript to continue using this application.

Compare $KURA vs $MGTX | Chartloom

Compare

$KURA vs $MGTX

Kura Oncology Inc · MeiraGTx Holdings PLC

KURA

Kura Oncology Inc

MGTX

MeiraGTx Holdings PLC

Compare $KURA vs $MGTX

Comparing Kura Oncology Inc and MeiraGTx Holdings PLC

KURAKura Oncology Inc

MGTXMeiraGTx Holdings PLC

KURAKura Oncology Inc

Market cap

$941M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.49x

Rev growth (TTM)

-7.3%

YTD performance

2.6%

52W performance

5.2%

FCF yield

-12.5%

MGTXMeiraGTx Holdings PLC

Market cap

$990M

P/E (TTM)

12.70x

Forward P/E (NTM)

—

Forward P/S (NTM)

27.71x

Rev growth (TTM)

948.3%

YTD performance

36.9%

52W performance

29.4%

FCF yield

1.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KURA

MGTX

Detailed metrics comparison

KURA

Kura Oncology Inc

MGTX

MeiraGTx Holdings PLC

Market Cap

KURA$941M

MGTX$990M

Enterprise Value

KURA$881M

MGTX$947M

Price

KURA$10.60

MGTX$10.69

P/E Ratio

KURAN/A

MGTX12.70x

P/S Ratio

KURA12.18x

MGTX2.49x

EV/Sales

KURA11.40x

MGTX2.38x

EV/EBITDA

KURA0.00x

MGTX4.63x

P/B Ratio

KURA19.56x

MGTX4.81x

P/FCF Ratio

KURAN/A

MGTX94.58x

EV/FCF

KURA-7.50x

MGTX90.47x

PEG Ratio

KURAN/A

MGTXN/A

Forward P/E (NTM)

KURAN/A

MGTXN/A

Forward P/S (NTM)

KURA6.49x

MGTX27.71x

Revenue (TTM)

KURA$77M

MGTX$398M

Revenue Growth (YoY)

KURA-7.3%

MGTX948.3%

Forward Rev Growth

KURA106.3%

MGTX-75.7%

Gross Margin (TTM)

KURA72.4%

MGTX97.9%

Operating Margin (TTM)

KURA0.0%

MGTX46.3%

EBITDA Margin (TTM)

KURA-410.2%

MGTX49.3%

Net Margin (TTM)

KURA-384.3%

MGTX19.9%

FCF Margin (TTM)

KURA-152.1%

MGTX2.6%

Net Income (TTM)

KURA$-297M

MGTX$79M

FCF (TTM)

KURA$-117M

MGTX$10M

EPS (TTM)

KURA-$3.34

MGTX$0.84

ROE (TTM)

KURA-20718.0%

MGTX74.6%

ROA (TTM)

KURA-4517.0%

MGTX29.4%

ROIC (TTM)

KURA-19400.0%

MGTX50.9%

Cash

KURA$70M

MGTX$143M

Debt

KURA$10M

MGTX$100M

Net Cash/Debt

KURA$60M

MGTX$43M

Current Ratio (TTM)

KURA4.73x

MGTX3.76x

Quick Ratio (TTM)

KURA4.47x

MGTX3.69x

Debt/Equity (TTM)

KURA0.20x

MGTX0.46x

Debt/Assets (TTM)

KURA0.0%

MGTX0.0%

Interest Coverage (TTM)

KURAN/A

MGTXN/A

Net Debt/EBITDA (TTM)

KURA0.00x

MGTX0.00x

Beta

KURA0.53

MGTX1.05

52W Performance

KURA5.2%

MGTX29.4%

YTD Performance

KURA2.6%

MGTX36.9%

% from 52W High

KURA-23.7%

MGTX-30.4%

% from 52W Low

KURA44.1%

MGTX61.5%

Asset Turnover (TTM)

KURA0.12x

MGTX1.48x

FCF Yield (TTM)

KURA-12.5%

MGTX1.1%

Earnings Yield (TTM)

KURA-31.5%

MGTX8.0%

Dividend Yield (TTM)

KURAN/A

MGTXN/A

Rule of 40

KURA-159.3

MGTX951.0

EV/GP/RG

KURA0.09

MGTXN/A

Ticker research

View KURA research View MGTX research

Metric	KURA Kura Oncology Inc	MGTX MeiraGTx Holdings PLC
Market & Valuation
Market Cap	$941M	$990M
Enterprise Value	$881M	$947M
Price	$10.60	$10.69
P/E Ratio	N/A	12.70x
P/S Ratio	12.18x	2.49x
EV/Sales	11.40x	2.38x
EV/EBITDA	0.00x	4.63x
P/B Ratio	19.56x	4.81x
P/FCF Ratio	N/A	94.58x
EV/FCF	-7.50x	90.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.49x	27.71x
Revenue & Growth
Revenue (TTM)	$77M	$398M
Revenue Growth (YoY)	-7.3%	948.3%
Forward Rev Growth	106.3%	-75.7%
Profitability
Gross Margin (TTM)	72.4%	97.9%
Operating Margin (TTM)	0.0%	46.3%
EBITDA Margin (TTM)	-410.2%	49.3%
Net Margin (TTM)	-384.3%	19.9%
FCF Margin (TTM)	-152.1%	2.6%
Net Income (TTM)	$-297M	$79M
FCF (TTM)	$-117M	$10M
EPS (TTM)	-$3.34	$0.84
ROE (TTM)	-20718.0%	74.6%
ROA (TTM)	-4517.0%	29.4%
ROIC (TTM)	-19400.0%	50.9%
Financial Health
Cash	$70M	$143M
Debt	$10M	$100M
Net Cash/Debt	$60M	$43M
Current Ratio (TTM)	4.73x	3.76x
Quick Ratio (TTM)	4.47x	3.69x
Debt/Equity (TTM)	0.20x	0.46x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.53	1.05
52W Performance	5.2%	29.4%
YTD Performance	2.6%	36.9%
% from 52W High	-23.7%	-30.4%
% from 52W Low	44.1%	61.5%
Efficiency & Yields
Asset Turnover (TTM)	0.12x	1.48x
FCF Yield (TTM)	-12.5%	1.1%
Earnings Yield (TTM)	-31.5%	8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-159.3	951.0
EV/GP/RG	0.09	N/A
Ticker research	View KURA research	View MGTX research

Valuation

P/E Ratio

MGTX

12.70x

P/S Ratio

MGTX

2.49x

KURA

12.18x

EV/FCF

KURA

-7.50x

MGTX

90.47x

Growth & revenue

Revenue Growth TTM

MGTX

948.3%

KURA

-7.3%

Forward Revenue Growth

KURA

106.3%

MGTX

-75.7%

Profitability & performance

Gross Margin

MGTX

97.9%

KURA

72.4%

ROE

MGTX

74.6%

KURA

-20718.0%

FCF Yield %

MGTX

1.1%

KURA

-12.5%

52-Week Performance

MGTX

29.4%

KURA

5.2%

Detailed metrics comparison

KURA

Kura Oncology Inc

MGTX

MeiraGTx Holdings PLC

Market Cap

KURA$941M

MGTX$990M

Enterprise Value

KURA$881M

MGTX$947M

Price

KURA$10.60

MGTX$10.69

P/E Ratio

KURAN/A

MGTX12.70x

P/S Ratio

KURA12.18x

MGTX2.49x

EV/Sales

KURA11.40x

MGTX2.38x

EV/EBITDA

KURA0.00x

MGTX4.63x

P/B Ratio

KURA19.56x

MGTX4.81x

P/FCF Ratio

KURAN/A

MGTX94.58x

EV/FCF

KURA-7.50x

MGTX90.47x

PEG Ratio

KURAN/A

MGTXN/A

Forward P/E (NTM)

KURAN/A

MGTXN/A

Forward P/S (NTM)

KURA6.49x

MGTX27.71x

Revenue (TTM)

KURA$77M

MGTX$398M

Revenue Growth (YoY)

KURA-7.3%

MGTX948.3%

Forward Rev Growth

KURA106.3%

MGTX-75.7%

Gross Margin (TTM)

KURA72.4%

MGTX97.9%

Operating Margin (TTM)

KURA0.0%

MGTX46.3%

EBITDA Margin (TTM)

KURA-410.2%

MGTX49.3%

Net Margin (TTM)

KURA-384.3%

MGTX19.9%

FCF Margin (TTM)

KURA-152.1%

MGTX2.6%

Net Income (TTM)

KURA$-297M

MGTX$79M

FCF (TTM)

KURA$-117M

MGTX$10M

EPS (TTM)

KURA-$3.34

MGTX$0.84

ROE (TTM)

KURA-20718.0%

MGTX74.6%

ROA (TTM)

KURA-4517.0%

MGTX29.4%

ROIC (TTM)

KURA-19400.0%

MGTX50.9%

Cash

KURA$70M

MGTX$143M

Debt

KURA$10M

MGTX$100M

Net Cash/Debt

KURA$60M

MGTX$43M

Current Ratio (TTM)

KURA4.73x

MGTX3.76x

Quick Ratio (TTM)

KURA4.47x

MGTX3.69x

Debt/Equity (TTM)

KURA0.20x

MGTX0.46x

Debt/Assets (TTM)

KURA0.0%

MGTX0.0%

Interest Coverage (TTM)

KURAN/A

MGTXN/A

Net Debt/EBITDA (TTM)

KURA0.00x

MGTX0.00x

Beta

KURA0.53

MGTX1.05

52W Performance

KURA5.2%

MGTX29.4%

YTD Performance

KURA2.6%

MGTX36.9%

% from 52W High

KURA-23.7%

MGTX-30.4%

% from 52W Low

KURA44.1%

MGTX61.5%

Asset Turnover (TTM)

KURA0.12x

MGTX1.48x

FCF Yield (TTM)

KURA-12.5%

MGTX1.1%

Earnings Yield (TTM)

KURA-31.5%

MGTX8.0%

Dividend Yield (TTM)

KURAN/A

MGTXN/A

Rule of 40

KURA-159.3

MGTX951.0

EV/GP/RG

KURA0.09

MGTXN/A

Ticker research

View KURA research View MGTX research

Metric	KURA Kura Oncology Inc	MGTX MeiraGTx Holdings PLC
Market & Valuation
Market Cap	$941M	$990M
Enterprise Value	$881M	$947M
Price	$10.60	$10.69
P/E Ratio	N/A	12.70x
P/S Ratio	12.18x	2.49x
EV/Sales	11.40x	2.38x
EV/EBITDA	0.00x	4.63x
P/B Ratio	19.56x	4.81x
P/FCF Ratio	N/A	94.58x
EV/FCF	-7.50x	90.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.49x	27.71x
Revenue & Growth
Revenue (TTM)	$77M	$398M
Revenue Growth (YoY)	-7.3%	948.3%
Forward Rev Growth	106.3%	-75.7%
Profitability
Gross Margin (TTM)	72.4%	97.9%
Operating Margin (TTM)	0.0%	46.3%
EBITDA Margin (TTM)	-410.2%	49.3%
Net Margin (TTM)	-384.3%	19.9%
FCF Margin (TTM)	-152.1%	2.6%
Net Income (TTM)	$-297M	$79M
FCF (TTM)	$-117M	$10M
EPS (TTM)	-$3.34	$0.84
ROE (TTM)	-20718.0%	74.6%
ROA (TTM)	-4517.0%	29.4%
ROIC (TTM)	-19400.0%	50.9%
Financial Health
Cash	$70M	$143M
Debt	$10M	$100M
Net Cash/Debt	$60M	$43M
Current Ratio (TTM)	4.73x	3.76x
Quick Ratio (TTM)	4.47x	3.69x
Debt/Equity (TTM)	0.20x	0.46x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.53	1.05
52W Performance	5.2%	29.4%
YTD Performance	2.6%	36.9%
% from 52W High	-23.7%	-30.4%
% from 52W Low	44.1%	61.5%
Efficiency & Yields
Asset Turnover (TTM)	0.12x	1.48x
FCF Yield (TTM)	-12.5%	1.1%
Earnings Yield (TTM)	-31.5%	8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-159.3	951.0
EV/GP/RG	0.09	N/A
Ticker research	View KURA research	View MGTX research